E7389
Jump to navigation
Jump to search
| E7389 | |
|---|---|
| Term | E7389 |
| Short definition | E7389 - A medicine used to treat certain types of breast cancer and liposarcoma (a type of soft tissue sarcoma) that have already been treated with other anticancer medicines. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
E7389 - A medicine used to treat certain types of breast cancer and liposarcoma (a type of soft tissue sarcoma) that have already been treated with other anticancer medicines. It is also being studied in the treatment of other types of cancer. E7389 blocks cell growth by stopping cell division and can kill cancer cells. It's a type of antimicrotubule agent. Also called eribulin mesylate and halaven
External links
- Medical encyclopedia article on E7389
- Wikipedia's article - E7389
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski